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Abstract Early detection of residual tumour and local
tumour progression (LTP) after radiofrequency (RF) ab-
lation is crucial in the decision whether or not to re-
ablate. In general, standard contrast-enhanced computed
tomography (CT) is used to evaluate the technique ef-
fectiveness; however, it is difficult to differentiate post-
treatment changes from residual tumour. Dual-energy
CT (DECT) is a relatively new technique that enables
more specific tissue characterisation of iodine-enhanced
structures because of the isolation of iodine in the im-
aging data. Necrotic post-ablation zones can be depicted
as avascular regions by DECT on greyscale- and colour-
coded iodine images. Synthesised monochromatic im-
ages from dual-energy CT with spectral analysis can
be used to select the optimal keV to achieve the highest
contrast-to-noise ratio between tissues. This facilitates
outlining the interface between the ablation zone and
surrounding tissue. Post-processing of DECT data can
lead to an improved characterisation and delineation of
benign post-ablation changes from LTP. Radiologists
need to be familiar with typical post-ablation image in-
terpretations when using DECT techniques. Here, we
review the spectrum of changes after RF ablation of
liver, kidney, and lung lesions using single-source
DECT imaging, with the emphasis on the additional
information obtained and pitfalls encountered with this
relatively new technique.
Teaching Points
•Technical success of RF ablation means complete destruction
of the tumour.
•Assessment of residual tumour on contrast-enhanced CT is
hindered by post-ablative changes.
•DECT improves material differentiation and may improve
focal lesion characterisation.
•Iodine maps delineate the treated area from the surrounding
parenchyma well.
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RFAblation
Minimally invasive therapies are increasingly used in
patients with malignant tumours, who are not suitable
candidates for surgical resection. The aim of local abla-
tive therapy is to induce cell death. Radio-frequency
(RF) ablation has attracted much attention in the last
decade because of its technological improvements and
has become a well-established technique to treat primary
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Technical success following RF ablation is due to the
complete destruction of the tumour. In case of incom-
plete necrosis of the tumoral volume, re-ablation of re-
sidual tumour can be pursued in order to improve tech-
nique effectiveness. For this reason, it is crucial to eval-
uate the results of the procedure early after ablation. The
ideal imaging technique should show the degree of necro-
sis of the malignant mass and detect residual tumour.
Imaging immediately after ablation also allows for the de-
tection of post-procedural complications and provides a base-
line for future follow-up comparisons. Unfortunately, the as-
sessment of residual tumour, usually by means of contrast-
enhanced computed tomography (CT), is hindered by post-
ablative changes, particularly at the periphery of a treated
lesion where blood flow is greatest [1, 2].
On pathology this represents a haemorrhagic rim corre-
sponding to an early inflammatory reaction to the necrotic
tissue [3, 4]. Today, contrast-enhanced CT is the standard ap-
proach to image early post-ablative changes in the liver [5, 6],
kidney [7], and lung [8]. However, some investigators have
reported that although complete necrosis may appear clearly
on contrast-enhanced CT, these findings do not always corre-
late with histopathological conclusions, which suggests that
there is limited diagnostic accuracy in the detection of residual
tumours [9–12].
Dual-energy CT
A well-known drawback of standard CT is that a num-
ber of different materials or tissues may show similar
attenuation behaviour at single radiation energy levels
and, with that, similar corresponding Hounsfield num-
bers. This poor attenuation difference can be partially
resolved by using dual-energy CT (DECT) technology
with material decomposition [13]. DECT is able to
achieve tissue attenuation sampling at two different en-
ergy spectra, which results in more specific information
beyond the typical Hounsfield units.
For already several years, three main technical ap-
proaches have been developed by various vendors for
the acquisition of dual-energy data: a single-source rap-
id kilovolt peak-switching technique, a dual-source
technique with an angular offset, and finally use of a
dual-layer detector that discriminates between high- and
low-energy photons [13]. The first two techniques ob-
tain dual-energy data simultaneously at two different
energy levels at typically 80 and 140 kVp, although
dual-source systems can also operate at 100 and 140
kVp (with an additional tin filter) in case of larger
patient sizes. The third technique uses the detected
high- and low-energy signal components in one CT
acquisition. More recently, a non-simultaneous, single-
source technique has been reported that applies a se-
quential data acquisition and a coregistration motion
correction algorithm [14]. It has been shown that
DECT improves material differentiation and works es-
pecially well in materials with large atomic numbers,
such as iodine and calcium, because their strong pho-
toelectric effect causes high attenuation at lower photon
energies [15]. The material decomposition technique as-
sumes that for any tissue an equivalent mixture of
Table 1 Early and long-term findings after RF ablation of liver lesions in successful and unsuccessful results, with the added value of the DECT
technique
Early findings Long-term findings
Successful General findings Non-enhancing area on contrast-enhanced CT
Regular hypervascular peripheral rim
Central hyperattenuation is indecisive for success
Regular borders of the ablation zone
Reduction in size
Added value of DECT Iodine void area
Improved contrast on the 40-keV images
Excellent conspicuity of the ablation zone
on iodine-coded images
Sharp depiction of the ablation zone’s edge
on iodine images
Unsuccessful General findings Irregular rim
Focal nodular thickening at the border
Focal hypervascular nodule (HCC)
Nodular attenuation differences around the
ablation zone (hypovascular metastasis)
Added value of DECT Higher residual tumour-to-liver contrast
on iodine images
Increased attenuation of iodine on the
low-keV images for detection of
subtle residual tumour
Better contrast between LTP and liver
parenchyma on iodine images
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water and iodine exists with similar spectral attenuation
properties. Consequently, after a material decomposition
calculation process, two base material maps can be
displayed, representing the concentrations of water and
iodine in each voxel. In contrast studies, these concen-
trations correspond to real water/iodine concentrations
in blood. All other materials (e.g. bone, fat) are de-
scribed as a mixture of both of these base materials
and will appear as hyper- or hypodensity in the base
pair maps. Iodine concentrations can be accurately
quantified. A recent study showed a 0.55 mg/cc mean
error when comparing calculated and true iodine con-
centrations in renal masses [16]. These calculated io-
dine concentrations (mg/cc) can be displayed for any
region of interest (ROI) as either a greyscale- or
colour-coded iodine image. Such iodine maps obtained
from DECT images are not a surrogate for dynamic
perfusion CT, as they merely provide a visualisation of
the iodine distribution in the tissues at one point in
time.
In addition to calculating base material maps, syn-
thesised or synthesised monochromatic images from
dual-energy CT, representing CT values (HU) over a
range of 40 to 140 keV, can also be obtained.
Compared to high-keV, low-keV images (closer to the
k-edge of iodine) typically provide improved contrast
between different structures, e.g. between a tumour and
surrounding normal parenchyma after injection of io-
dinated contrast material. On the other hand, noise is
more prominent in these lower keV images [17].
Synthesised monochromatic images at 77 keV corre-
spond best to the effective energy of a single-energy
Fig. 1 Hypovascular liver metastasis. A 53-year-old female
undergoes surgery for rectal carcinoma and then receives RF
ablation in a focal liver lesion. Eight months later, a local
tumour progression (first column) at the cranial side of the
ablation zone (large arrow) can be seen as an intermediate
density (small arrow). In this straightforward case, the tumoral
tissue is equally well depicted on the 40- and 70-keV images as
on the greyscale iodine images. Noise is more prominent on the
40-keV image however. Iodine maps are encoded using a rainbow
template with a colour coding from high to low iodine
concentration, being from red (through yellow) to blue
respectively. The intermediate colour represents a tumour (small
arrow). On PET/CT a vivid FDG uptake is seen (arrowhead).
Twenty-four hours after a second RF ablation (second column),
a sharp delineated ablation zone is found. On all reconstructions,
the avascular nature of the ablation zone is well demonstrated.
The contrast with the surrounding liver parenchyma appears
highest on the colour-coded iodine map. No FDG uptake is seen
on the PET/CT image. The PET/CT 3 months later (not shown)
does not show signs of tumoral activity
R
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Fig. 2 Hypervascular metastasis.
A 63-year-old male undergoes
follow-up CECT in the arterial
phase 4 years after ablation of a
renal cell carcinoma. This reveals
a 26-mm hypervascular lesion in
segment VII of the liver, which is
histopathologically proven to be a
metastasis of the RCC. RF
ablation is performed. a Twenty-
four hours after the ablation, a
DECT is performed. The water
map image shows a centrally
located hyperdensity in the
ablation zone (arrow),
corresponding to intense charring
and desiccation of the treated
lesion. Note that this hyperdensity
is less visible on the iodine maps.
The arterial phase image does not
demonstrate any focal
hypervascularity at the border of
the ablation zone. No rim
enhancement can be seen. The
delineation of the total ablation
zone is better depicted on the
portal-venous phase greyscale-
and colour-coded iodine images,
because the amount of iodine in
the liver parenchyma is higher. b
On the 1-year follow-up CECT, a
smooth delineation of the ablation
zone is noticed, which serves as
proof of the technical success of
the ablation. The central
hyperdensity however is still
noticeable (arrowheads)
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120-kV scan [18], such that the image contrast simu-
lates a traditional single-energy CT scan. By assessing
the DECT images, an optimised keV window based on
the contrast-to-noise ratio between tissues can be cal-
culated. In RF ablation, an improved contrast is typi-
cal ly obta ined between the abla t ion zone and
surrounding normal liver parenchyma. A scatterplot
analysis, which estimates the material concentration in
each voxel, can also help to differentiate different
structures in the ROIs. Research is currently ongoing
with regard to adequate quantification of the acquired
DECT data. Several potential candidate parameters are
Fig. 3 Hepatocellular carcinoma. A 43-year-old male with cirrhosis
undergoes gadolinium enhanced MRI, revealing a hepatocellular
carcinoma in segment VII, typical for a hepatocellular carcinoma,
which is confirmed through biopsy. a Twenty-four hours after RF
ablation, the patient undergoes a standard unenhanced CT scan and
a contrast-enhanced DECT. The unenhanced CT shows a central
area of high attenuation (arrowhead) within the ablation zone,
which has a lower visibility on the water map reconstruction. The
central hyperdensity is well noticeable on the synthesised
monochromatic 40-keV but less so on the 70-keV images, and it
is hardly visible on the iodine images. On the 40- and 70-keV
synthesised monochromatic images, the ablation zone can be
depicted as a lesion with a hypervascular peripheral rim (white
arrows). On the greyscale- and colour-coded iodine images, we
can better appreciate the focal hypervascular thickening at the
posterior border (yellow arrows) than with the synthesised
monochromatic images. b Due to the suspicious nature of the
focal thickening seen in a, a shorter follow-up period is adhered
to and a DECT is performed 5 weeks post-RF ablation. A focal
hypervascular nodule is well depicted on the 70-keV (white
arrow) images, although more clearly observable on the 40-keV
ones; however again it is more evident on the greyscale- and
colour-coded iodine images. Biopsy of this region confirms
residual HCC. c Twenty-four hours after the second ablation, the
greyscale- and colour-coded iodine images show significant iodine
rim uptake around the ablation zone in the arterial phase (arrows).
Therefore, a focal hypervascular remnant cannot be appreciated.
This rim disappears on the venous phase (not shown). MRI after
10 weeks reveals no signs of reactivation
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being screened for usefulness within the RFA context,
such as CT numbers (i.e. Hounsfield unit curves) [19,
20], contrast-to-noise ratios [20, 21] or iodine concen-
trations [22]. Compared to standard CT, DECT may
have the potential to improve focal lesion characterisa-
tion, and it is a promising tool to supply quantitative
data in addition to traditional morphological informa-
tion. The associated radiation dose with DECT will
depend on the applied technology. Although specific
clinical studies comparing the dose efficiency of differ-
ent technologies are still lacking, current data suggest
that DECT imaging with dual-source systems does not
necessarily cause additional radiation exposure for the
patient compared to standard CT [17, 23, 24].
Radiation dose data on the rapid kilovolt peak–
switching technique to date are still inconclusive and
reports from other approaches are scarce or nonexistent
[25]. However, the increased informational content and
post-processing flexibility of DECT data create addi-
tional opportunities for dose saving, such as the crea-
tion of virtual unenhanced images from a contrast-
enhanced scan [25].
The purpose of this pictorial essay is to display post-
ablative changes on contrast-enhanced CT with a single-
source rapid kilovolt peak-switching technique in order
to identify the additional information provided by
DECT imaging and to describe the pitfalls of this rela-
tively new technique in the evaluation of RF ablation’s
technical success.
DECT imaging protocol
Fast kilovoltage switching CT was performed on a 64-
slice CT (Discovery CT750 HD, GE Healthcare,
Milwaukee, WI, USA) after IV administration of
120 cc contrast at 2.5 cc/s. Scan data were acquired
at 40-mm collimation using predefined GSI protocols
at CTDIvol values between 15.02 and 25.53 mGy.
Fixed tube currents (between 375 and 600 mA) were
used as our DECT scanning mode is not compatible
with the automated tube current modulation system of
the scanner. Images were processed on a workstation
(AW4.4; GE Healthcare) using the Gemstone Spectral
imaging application. Three types of images were recon-
structed for analysis: synthesised monochromatic im-
ages from 40 to 140 keV, greyscale- and colour-coded
iodine images (with ‘rainbow’ colour map).
Liver ablation
Necrosis caused by thermal damage is characterised by
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Fig. 4 Renal cell carcinoma. An ultrasound reveals a renal mass
in a 72-year-old male. a Venous phase DECT confirms a lesion
in the left kidney. On the water map images, the lesion is
exophytic and isodense compared to the kidney parenchyma
(arrows). The synthesised monochromatic 40-keV greyscale-
coded and colour-coded iodine images show a hypovascular
les ion compared to the kidney parenchyma. A biopsy
demonstrates a renal clear cell carcinoma. b On the iodine-
coded image (left), three ROIs are selected: L1 (red) in the
RCC; L2 (blue) in the renal vein; L3 (yellow) in the
unaffected kidney parenchyma. The estimated amounts of
iodine in the ROIs are presented in the right lower corner
(mean value and standard deviation in 100 μg/cm3). On the
spectral HU curve (right), the renal vein (L2) and RCC (L1)
represent overlapping curves, suggesting similar iodine content.
The normal kidney parenchyma (L3) has a markedly higher
curve in the lower keV range, confirming a higher iodine
uptake. c Axial (left column) and coronal (right column)
reconstructions from a contrast-enhanced venous phase DECT,
24 h post-RF ablation. The water map images show very poor
hyperattenuation in the ablated zone (arrowheads). The contrast
difference between the ablation zone and the kidney parenchyma
is well demonstrated on the synthesised monochromatic
40- and 70-keV images. The colour-coded iodine images show
well-depicted areas of intermediate density on the axial
reconstructions (black arrows) surrounding the ablation zone.
The ax i a l images o f the syn the s i sed monoch roma t i c
reconstructions less clearly visualise these regions. The
multiplicity suggests a benign post-ablative finding, probably
corresponding to transient thermal damage to the bordering
kidney parenchyma. No definitive conclusion can be made
concerning residual tumour solely relying on these images.
However, compared to the pre-ablation imaging, we can
assume that the tissue in question is a normal kidney
parenchyma. At the outer margin of the ablation zone, a region
of intermediate density is depicted. The coronal reconstructions
are essential to prove the continuity with regard to the kidney
parenchyma (white arrows) . d On the follow-up CECT
15 months later, the focally enhanced tissue at the lateral side
shows no signs of growth (arrow), thus confirming the absence
of residual tumour
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enhancing area on contrast-enhanced CT (Table 1). Due
to this lack of internal vascularity, iodine maps are well
suited for delineating the treated area from the liver
parenchyma (Figs. 1 and 2a). Dual-energy CT has the
possibility to extract iodine from the enhanced images
to create water map images and thus potentially skip
true unenhanced images, as shown in Fig. 3a. This un-
doubtedly offers a considerable advantage in limiting
radiation dose exposure [23]. However, a drawback is
that current DECT techniques do not produce water
map images with the same contrast-to-noise ratio as true
unenhanced images [26].
Frequently, a hyperattenuation centrally within the
ablation zone can be seen on unenhanced images
[27]. It is thought that this area of high density corre-
lates to a region of greater cellular disruption in the
centre of the ablation zone [3], reportedly caused by
the intense charring of the severely desiccated coagu-
lated lesion [28]. It has usually disappeared by the time
the next follow-up CT examination takes place, but can
Fig. 4 (continued)
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Fig. 5 Renal cell carcinoma. A
lesion in the right kidney of a 73-
year-old male is confirmed as
being a hypernephroma through
biopsy. The patient is treated with
RF ablation, while cooling the
pyelum with a double j-stent. a
The DECT obtained 24 h post
ablation shows a hyperdense
region in the ablation zone on the
water map images (white arrow).
On the synthesised
monochromatic 40-keV images, a
sharp delineation of the ablation
border is assessed, without the
presence of any internal
hyperdensity in the ablation zone.
A post-procedural, streaky, soft-
tissue attenuation can be seen in
the surrounding perirenal fat
(arrowheads). The avascular zone
is well depicted on the greyscale-
and colour-coded iodine images.
In this window level, some
yellowish coloured pixels are
seen in the centre of the ablation
zone on the colour-coded iodine
images (black arrow), lying in the
extension of a branch of the renal
artery, explainable as being
spilled iodine due to arterial
perfusion. b DECT
reconstructions at a 3-month
follow-up stage show an overall
stability in the size of the ablation
zone. The ablated zone is still
slightly hyperdense on the water
map image (arrow). There is no
uptake of iodinated contrast on
the greyscale- and colour-coded
iodine images, which proves that
this area is completely avascular
and confirms that the colour
pixels seen in a were not a sign of
tumour activity
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persis t for a longer t ime [29] (Fig. 2b). This
hyperattenuation is observable on both the water map
and true unenhanced images. Despite the absence of
iodine, this can also be seen on the iodine-coded im-
ages, since the hyperattentuated area is represented as a
combination of both water and iodine after material
decomposition (Fig. 2a). Meticulous comparison of wa-
ter and iodine-coded images allows for differentiation
of this central hyperattenuation after RF ablation and
structures enhancing after IV contrast administration.
The reader should however be aware of the lower im-
age quality of water images with respect to true
unenhanced images (Fig. 3a), as also reported on
dual-source DECT [20]. Similar to the study of Lee
et al. [20], we observed sharp depiction of the edge
of the ablation zone of the iodine images. Contrary to
their findings obtained using a dual-source DECT sys-
tem, our experience with single-source DECT images
did not prove an internal homogeneity of the ablation
zone on the iodine images.
Immediately after ablation, it is common to find a
hyper-attenuating halo surrounding the ablation zone on
CECT, correlated to an increase in arterial perfusion
due to capillary leakage from thermal damage [30].
The circumferential enhancement is predominantly vis-
ible on the arterial phase and can be very prominent in
some cases (Fig. 3c), obscuring the interpretation of
residual tumour. An irregular or nodular rim can indi-
cate the presence of residual tumour, although benign
variations do occur [30–32]. When focal thickening at
the border of the ablation zone is unclear, a shorter
follow-up period is recommended [32]. Previous stud-
ies have shown that a hypervascular rim remains visi-
ble in 89 % of cases after 1 month, in 56 % of cases
between 1 and 3 months, and in 22 % of cases be-
tween 3 and 6 months [33]. Ideally, the volume of
Fig. 6 Renal cell carcinoma. A
40-year-old female is diagnosed
with a suspicious lesion in the right
kidney on ultrasound. After
consulting her urologist, the patient
opts for RF ablation. a CECT
shows a thick-walled cystic lesion
in the right upper pole, graded as a
Bosniak 4 cyst. b The true
unenhanced polychromatic CT
image (left), 24 h post ablation,
shows a hyperdense change in the
ablation zone (arrow). This finding
cannot be confirmed on the water
map reconstructions. c The
imaging appearance of the ablation
zone 24 h (first row), 3 months
(second row), and 18 months (third
row) after RF ablation. On the 24-h
post-ablation series, the delineation
of the ablation zone is clearly
observable on all reconstructed
images; however, the 40 keV
image is of superior quality when
compared to the 70-keV image
(arrowheads). On the iodine-coded
images, the internal high
attenuation is unexpectedly (no
iodine content) still visible within
the avascular zone (arrows). No
suspicious nodular enhancement is
observed at the border of the
ablation zone. DECT from 3- and
18-month follow-up depicts an
involution of the avascular zone.
There is a loss of the internal high-
attenuation changes. There is no
evidence of local tumour
progression
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thermal necrosis exceeds the limits of the metastasis by
1 cm in all dimensions [34]. Residual tumour will per-
sist as a focal nodular enhancement in the periphery of
the ablation zone (Fig. 3b). For dual-energy CT, the
increased attenuation of iodine on the low-keV (e.g.
around 40 keV) images is better suited for detecting
any subtle density differences around the ablation zone
(Fig. 3b). Adding colour-coding enhances the visibility
of the contrast in the image.
The water-iodine material decomposition can high-
light areas containing iodinated contrast. Iodine maps
are superior to synthesised monochromatic images for
the qualification of contrast uptake. Consequently, a
hypervascular nodule with a higher inflow of iodine
is better depicted on the iodine maps when compared
to synthesised monochromatic images (Fig. 2b).
Kidney ablation
Ablation zones in the kidneys lack iodine content and
are often wedge shaped because of peripheral infarc-
tions [35] (Table 2). Determining a tumour’s iodine
concentration before RF ablation can provide a base-
line for future follow-up assessments (Fig. 4a, b).
Iodine concentrations that are similar to the original
tumour post ablation can be a sign of local tumour
progression. The iodine content can be assessed quali-
tatively as well as quantitatively in the investigated
ROI (Fig. 4b).
When evaluating the contrast uptake in a lesion, it
is imperative to compare the lesion’s density on the
water map images to that on the synthesised mono-
chromatic images in order to be able to appraise pos-
sible ‘enhancement’ . The iodine content can be
assessed qualitatively based on the iodine-coded im-
ages as well as quantitatively when expressed in io-
dine concentrations (mg/ml) (Fig. 4b) in the investigat-
ed ROI. Enhancement can also be demonstrated by
comparing the iodine concentration in the lesion to a
surrounding vascular structure after an IV contrast in-
jection. When evaluating colour-coded iodine maps, it is
important to compare iodine concentrations in the ROI
to those in adjacent structures, because windowing (as a
diagnostic tool) causes variability in the colour
spectrum.
As with liver lesions, the extent of necrosis in the
ablation zone can be assessed more accurately on 40-
keV rather than on 70-keV synthesised monochromatic
images. Also, the iodine maps show clear differentia-
tion between avascular and viable tissues. Adjacent to
the avascular zone, regions of intermediate vascularity
can be seen that appear most pronounced on colour-
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transient thermal damage to the adjacent kidney paren-
chyma, causing a temporary blood flow decrease in
this area. Multi-planar reconstructions are vital in the
assessment of questionable regions after the RF
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ablation procedure (Fig. 4c). Although avascularity is
by definition a sign of successful ablation, the ablation
zone can show remnants of iodine concentration, pos-
sibly due to the extravasation of iodine which itself is
caused by vascular damage (Fig. 5a).
The majority of ablation zones are hypodense in
nature; however, it is not uncommon to have a variable
degree of haemorrhagic necrosis in the necrotic area.
This degree of attenuation is not predictive of tech-
nique effectiveness (Fig. 6c). Since the quality of the
water maps is less compared to the true unenhanced
images, spontaneous hyperdensity may be missed by
this reconstruction technique (Fig. 6b).
In the contrast to rim enhancement that is commonly
found in liver ablations, this phenomenon has only been
observed occasionally in ablated renal parenchyma [25].
If present, it resolves quickly and is only marginally
visible after 3 months [36]. Post-ablative changes in
the perirenal fat are predominantly seen as streaky soft
tissue attenuations (Fig. 5a), which resolve to a domi-
nant band or halo over time (Fig. 4d). Long-term fol-
low-up findings include the development of fat between
the ablation zone and normal kidney parenchyma [37,
38] (Fig. 4d). The majority of kidney ablations show
little to no reduction in size within the first 6 to
12 months [39, 40]; however, earlier shrinkage is not
uncommon (Fig. 6c).
Lung ablation
When performing RF ablation of lung lesions, the goal
is to achieve an avascular region, void of any iodine
enhancement (Table 3). Dual-energy CT in the lungs
can depict an abnormal blood flow distribution, improv-
ing the detection of acute pulmonary embolism [41]. In
addition, we believe that the complete avascular ablative
area post ablation is well depicted on the iodine-coded
images as an iodine-void area. Therefore, iodine map-
ping may be an excellent method to evaluate the tech-
nique effectiveness and also delineates a more realistic
assessment of the necrotic zone after ablation (Fig. 7a).
On CECT imaging, the absence of iodine uptake in an
ablated lung lesion is hard to identify since the bound-
ary between the ablated and non-ablated tissue cannot
be clearly defined (Fig. 8).
The typical finding on lung window CT during and
after RF ablation is ground-glass opacification sur-
rounding the treated tumour, which is fully circumfer-
ential (Fig. 8) in the majority of cases, but can also be
partial (Fig. 9a). It is less common to find ground-glass
opacification along the electrode tract. These ground-
glass changes typically lead to an overestimation of
the necrosis zone by 2–4 mm [42]. The distinction
between the inner necrotic zone and the outer
haemorrhagic viable zone is not clear on CT imaging;
thus, the effective necrotic zone is easily overestimated
[8]. As a result, the boundary between the ablated and
non-ablated zones cannot be clearly defined using tra-
ditional morphologic imaging (Fig. 7b).
It is unclear how the iodine images provide a more
realistic view of the necrotic zone after ablation. Kawai
et al. [43] evaluated the feasibility of distinguishing
ground-glass opacification in adenocarcinomas from that
in a haemorrhage or inflammation. They found that
there was an increased iodine-related attenuation in ad-
enocarcinomas, but not in a pulmonary haemorrhage or
in inflammatory changes. These findings led us to in-
vestigate the possible benefits of using iodine maps to
distinguish residual tumours (Fig. 9) from the common
post-ablative changes found in lung ablation. On follow-
up CECT, centrally located enhancements or enhance-
ments that were not present immediately after the RF
ablation are indicative of malignancy [44]. Even without
enhancement, growth of the ablation zone (after 8 to
10 weeks) or any peripheral nodule is a cause for con-
cern. A change from ground-glass opacity to solid opac-
ity also requires further investigation [43]. Positron
Fig. 7 Pulmonary metastases. A 77-year-old female, with
a known melanoma, undergoes a PET/CT that shows a
hypermetabolic nodule in the right upper lobe (not in our
possession). The biopsy is non-conclusive. The therapeutic
option is RF ablation. a Imaging is performed before (first
column) and 24 h after (second column) RF ablation. The 70-
keV lung window shows a focal nodule of 11 mm (white arrow)
in proximity of a blood vessel. This nodule is hyperdense on the
synthesised monochromatic 40-keV images and shows iodine
content on the greyscale- and colour-coded iodine maps
(circles). Destructive lung parenchyma is seen after the ablation
as an irregular hyperdensity on the lung window (black arrows).
The synthesised monochromatic 40-keV reconstructions show
very heterogeneous densities in this region. The vessel on the
anterior side is still intact (white arrowhead). On the iodine
maps, we clearly observe the absence of iodine uptake (yellow
arrowheads). PET/CT shows no activity in this region. b
Imaging is performed before (first column) and 24 h after
(second column) microwave ablation (MWA). After 6 months, a
well-circumscribed consolidation is seen on the 70-keV lung
window and synthes i sed monochromat ic 40-keV image
(arrows). The greyscale- and colour-coded iodine maps show
no focal iodine uptake. This consolidation is hypermetabolic on
PET/CT. As a result of the discrepancy between the morphologic
and metabolic imaging methods, and the proximity of the blood
vessel, which could lead to a heat-sink effect, the patient opts for
further focal thermal treatment through microwave ablation.
Twenty-four hours after ablation, a large heterogeneously
shaped densi ty is recognised on the lung window. The
greyscale- and colour-coded iodine maps very clearly show the
zone without internal contrast uptake (arrowheads) when
compared to the 40-keV images. Again, a photopenic area is
seen on the PET/CT image
R
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emission tomography/CT is considered the optimal
follow-up tool after focal ablation in the lung.
Residual disease can be detected through tracer uptake,
most likely at the periphery of the ablation zone
(Fig. 9b). On follow-up, increased or new metabolic
activity located centrally (Fig. 7b) or at the outer rim
Fig. 8 Pulmonary metastases. A
69-year-old female, with a history
of breast cancer diagnosed 9 years
prior, shows a hypermetabolic
nodule in the inferior lobe of the
right lung on PET/CT. A biopsy
reveals a metastasis of a ductal
mammary carcinoma. An RF
ablation is performed. Imaging of
the lesion 1 day before (first
column), 24 h after (second
column), and 3months after (third
column) complete RF ablation is
performed. Before ablation, an 8-
mm well-circumscribed nodule is
depicted on the synthesised
monochromatic 70-keV lung
window, FDG-avid on the PET
scan (white arrows). Internal
vascularisation is clearly




iodine images (circles). The
changes found 24 h post ablation
are a ground-glass appearance
(yellow arrowheads) around the
lesion and the vanishing of the
previously seen iodine uptake in
the lesion. The post-ablative
avascular zone surrounding the
necrotic lesion can be delineated
on the iodine images as darker
areas (yellow arrows). On the
lung window images after
3 months, the treated area has
transformed into a homogeneous,
well-delineated area of high
attenuation. PET/CT images
reveal no activity after the RF
ablation. The greyscale- and
colour-coded iodine images show
a reduction in size of the avascular
region
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of the ablation zone is a sign of progressive tumour
activity [44].
Conclusion
Post-ablative changes can hamper the evaluation of post-ablation
zones. Our pictorial review illustrates the potential improvements
that DECT provides in the differentiation of tissues. We believe
that DECT can be a valuable asset in the differentiation of
residual tumours from benign inflammatory changes, commonly
found after the ablation of liver, kidney, and lung tumours.
Further investigation is required because of the limited clinical
experience with this relatively new technique.
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priate credit to the original author(s) and the source, provide a link to the
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Fig. 9 Pulmonary metastases. A focal lung nodule is found in a 65-year-
old female diagnosed with ovarian carcinoma. A biopsy reveals a non-
small-cell carcinoma. A multidisciplinary team meeting leads to the
choice for RF ablation treatment. Coronal reconstructions of the lesion
in the right upper lobe before (first column), 24 h after the first RF
ablation (second column), and 24 h after microwave ablation (third
column) are demonstrated. a A focal nodule of 9 mm in the upper lobe
is seen on the 70-keV lung window (black arrow) prior to the ablation.
This nodule is “enhanced” on the synthesised monochromatic images
compared to the water map image. This “increase in density” is better
appreciated on the 40-keV rather than on the 70-keV images. Twenty-four
hours after the first ablation, the spicular nodule appears enlarged on the
lung windows. On the 40-keV image, a focal enhancement (arrow) is
noted at the inferior border of the ablation zone, again more clearly
visible compared to the 70-keV image. After re-ablation with
microwave technique, we notice more important changes on the lung
window than after the first ablation. b The iodine content of the
hypermetabolic lesion before the RF ablation is most observable on the
greyscale- and colour-coded iodine images (circles). The nodule is
hypermetabolic on PET/CT. Twenty-four hours after the first ablation,
the greyscale- and colour-coded iodine maps clearly show the focal area
of iodine uptake (white arrows) on the inferior border. PET/CT confirms
hypermetabolic remnants (yellow arrow). After re-ablation, the larger
area of thermal damage has lost its internal focal iodine uptake, which
is most appreciable on the iodine-coded images (arrowheads). Images
after the re-ablation lack FDG uptake on PET/CT
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